SKQ1 [934826-68-3]
Referencia HY-100474-5mg
embalaje : 5mg
Marca : MedChemExpress
| Descripciòn |
SKQ1 is a mitochondrial-targeted antioxidant with the high mitochondrion membrane penetrating ability and potent antioxidant capability[1]. |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| In Vitro |
Direct treatment of tumor infiltrating leukocytes with SkQ1 does not influence their cytotoxicity against Panc02 cells. While SkQ1 does not affect viability of the cell lines, this drug at 500 nM concentration reduces heavily the proliferation of human PDAC cells[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
| In Vivo |
Regarding systemic angiogenic factors, it is observed in serum of Pancreatic ductal adenocarcinoma (PDAC) bearing mice a decrease in KC in the group of continuous treatment with SkQ1. Treatment of the mice with SkQ1 increases the level of VEGF molecules. The amount of MIP1a and prolactin is reduced in all SkQ1 treatment groups or after the follow-up treatment, respectively. Also, an increase in the IL-6 and IL-13 amount is found in the SkQ1 treated groups. TGF-b amount is decreased in the pretreatment setting. On the contrary, all schemes of the SkQ1 treatment decrease the NKT cell percentage. The SkQ1 treatment has prolonged the median survival of PDAC-bearing mice, but the difference does not reach the level of significance defined[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
| Ensayo clínico |
|
||||||||||||
| Peso molecular |
617.60 |
||||||||||||
| Fòrmula |
C36H42BrO2P |
||||||||||||
| No. CAS | |||||||||||||
| Appearance |
Solid |
||||||||||||
| Color |
Yellow to brown |
||||||||||||
| SMILES |
O=C(C(CCCCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)=C4)C(C)=C(C)C4=O.[Br-] |
||||||||||||
| Envío | Room temperature in continental US; may vary elsewhere. |
||||||||||||
| Almacenamiento |
4°C, stored under nitrogen, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture) |
||||||||||||
| Solvente y solubilidad |
In Vitro:
DMSO : 100 mg/mL (161.92 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles. Select the appropriate dissolution method based on your experimental animal and administration route.
For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
|
||||||||||||
| Pureza y Documentación | |||||||||||||
| Referencias |
|

